NCT04181437

Pharmacokinetic Interaction and Safety Between NVP-1203-R1 and NVP-1203-R2

A Phase I Clinical Trial to Evaluate the Pharmacokinetic Interaction and Safety Between NVP-1203-R1 and NVP-1203-R2 in Healthy Adult Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: NVP Healthcare · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare the pharmacokinetics and safety between NVP-1203-R1 and NVP-1203-R2

Detailed description

pharmacokinetics and safety between NVP-1203-R1 and NVP-1203-R2

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	NVP-1203-R1	1 tablet, Single oral dosing
DRUG	NVP-1203-R2	1 tablet, Single oral dosing
DRUG	NVP-1203-R1 and NVP-1203-R2	NVP-1203-R1,1 tablet and NVP-1203-R2, 1 tablet, co-administration, single oral dosing

Timeline

• Start date: 2020-05-01
• Primary completion: 2020-05-17
• Completion: 2020-05-29
• First posted: 2019-11-29
• Last updated: 2020-09-01

Locations

1 site across 1 country: South Korea